English Funding For Aquipta Targets AbbVie’s Migraine Drug To 170,000 People

 
• By Neena Brizmohun
  
Pfizer biohaven migraine deal
Aquipta is an oral, once-daily treatment for migraine • Source: Nielsen Hobbs; the Pink Sheet | Shutterstock image
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from United Kingdom

More from Europe